The PIKfyve Inhibitor Apilimod: A Double-Edged Sword against COVID-19
Publication year
2021Source
Cells, 10, 1, (2021), article 30ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Tumorimmunology
Journal title
Cells
Volume
vol. 10
Issue
iss. 1
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [203587]
- Electronic publications [101944]
- Faculty of Medical Sciences [80231]
- Open Access publications [70660]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.